SYDNEY, NSW, AUSTRALIA, Ianuali 31, 2021 /EINPresswire.com/ - Ua hauʻoli ka noiʻi Cannabis noi e haʻi ʻO Labs Aruma Ua hui pū ʻo (Aruma) i ka nānā loiloi lōʻihi loa o Australia o nā huahana kaukana lāʻau, ka Nā Kalinika CA Nānā Nānā (CACOS*), me ka nānā ʻana i ka hōʻiliʻili ʻana i nā ʻikepili mai nā mea maʻi me ka endometriosis.
ʻO Endometriosis kahi maʻi ʻehaʻeha i ʻike ʻia ma mua o 11% o nā wahine Australia, e like me ka Endometriosis Australia. Hoʻohālikelike ʻia ia e ke alo o nā kiko endometrial, i loaʻa maʻamau i loko o ka kōpū, i nā wahi ʻē aʻe o ka ʻōpū. ʻO ka hoʻemi ʻana i ka maikaʻi o ke ola no nā wahine me ka endometriosis i koho ʻia ma A $ 4 biliona no kēlā me kēia makahiki (Ernst & Young (2019): Ke kumukūʻai o Endometriosis ma ka Hōʻike ʻo Australia).
E komo ana nā wahine 200 i ke aʻo ʻana e kiaʻi i ka palekana a me ka pono o ka lāʻau hiki ke hoʻohana ʻia me kahi koho hoʻoponopono a me ke koho hoʻomalu no ka ʻeha mau loa o ka refractory, kahi ʻōuli maʻamau o ka endometriosis.
NĀ KUMU KULA MAU:
-ʻUmi ʻia nā wahine Australia e komo i ka noi nānā endometriosis Applied Cannabis Research ma o CA Clinics.
-E manaʻo ʻia ka hopena o ka endometriosis ma mua o 11% o nā wahine Australia a ʻo ka hoʻemi ʻia o ke ola e manaʻo ʻia e hopena i kahi kumukūʻai kaiāulu o $ 4 biliona i kēlā me kēia makahiki.
-E hoʻopili ʻia ʻo Aruma i kā lākou huahana cannabis lāʻau lapaʻau i loko o ke aʻo ʻana, a ʻo Applied Cannabis Research e ʻohiʻohi i nā ʻikepili e pili ana i kona palekana a me kona pono, a me ka ʻimi ʻana i ka ʻeha a me ka maikaʻi o ke ola (QOL) i nā maʻi i kuhikuhi ʻia i kahi huahana Aruma.
-ʻO ka Endometriosis Study kahi sub-study o CACOS, kahi ʻike nānā e pili ana i nā hopena olakino o 3,000 mau maʻi ma ka ʻāina holoʻokoʻa ma CA Clinics i kuhikuhi ʻia nā huahana cannabis lāʻau no ka mālama ʻana i nā kūlana refactory.
ʻO Louis Williams, Luna Nui o Aruma i ʻōlelo:
"Hōʻike ka noiʻi e kali pinepine nā wahine me ka endometriosis a hiki i ʻewalu mau makahiki ma mua o ka loaʻa ʻana o kahi hōʻailona. I loko o kēlā manawa, hiki iā lākou ke ʻeha i ka ʻeha hoʻonāwaliwali, ke kaumaha, a me ka emi o ke ola. ʻO kā mākou pahuhopu, ma o kēia hui pū ʻana me Applied Cannabis Research, ʻo ia ka hōʻiliʻili ʻana i nā ʻike i hōʻike ʻia e ka mea hoʻomanawanui e ʻike ai inā he mana kūpono ko kā mākou formulate kūikawā ma ke ʻano o ka mālama ʻana i ka ʻeha e pili pinepine ana me ka endometriosis. Ua kūpaʻa ʻo Aruma e kōkua i ka loaʻa ʻana o nā hopena no nā mea maʻi e hana i kahi ʻokoʻa maoli i ko lākou ola. "
ʻO Dr John Barlow, ka mea noiʻi nui ma Applied Cannabis Research i ʻōlelo: "ʻO ka Endometriosis kahi maʻi hoʻomau a hoʻonāwaliwali hoʻi e pili ana iā 11% o nā wahine. Hoʻohālikelike ʻia ia e ka infertility a me ka ʻeha pelvic mau, akā mau nō nā koho lapaʻau ʻana. Hoʻohana pinepine ʻia ka lāʻau cannabis no ka mālama ʻana i ka ʻeha refactory akā ʻaʻole ʻike ʻia kona hopena ma ke ʻano he therapeutic no ka ʻeha endometrial. E hōʻike mua kēia noiʻi ninaninau i ka pono o ka cannabis e mālama ai i ka ʻeha endometrial a me ka hōʻike ʻana i kahi o nā form cannabinoid ka mea mana loa. ”
ʻO Dr Mark Hardy, ka hoʻomalu hoʻomalu a me ka Luna Hoʻokele Lapaʻau ma CA Clinics i ʻōlelo:
"ʻO kaʻeha mau e pili ana me ka endometriosis kahi pilikia paʻakikī a hoʻonāwaliwali hoʻi no nā miliona o nā wahine ma ka honua holoʻokoʻa. ʻO nā hopena maikaʻi o ka cannabis olakino i ka ʻeha ka mana e lawa ai e noʻonoʻo ai i ka cannabis olakino ma ke ʻano he koho hoʻokele ʻeha, hoʻopili ʻia me nā mālama o kēia wā. Ke ʻimi ʻia nei ʻo Cannabinoids no kā lākou hopena i ke kaʻina o ka angiogenesis, kahi ʻano nui o ka pathology o endometriosis, a me kā lākou anti-inflammatory waiwai. He mea nui ka noiʻi ʻana i hōʻike ʻia e ka CACOS no ka hoʻomaikaʻi maikaʻi ʻana a me nā hopena olakino. ”
ʻO Dr Davina Hiley, CA Clinics, hoʻohui ʻia:
"He nui nā wahine e ʻeha i nā ʻōuli endometriosis kaumaha. ʻO nā kuʻuna maʻamau e like me ka hoʻōla hormonal, analgesia, anti-inflammatories a i ʻole ke ʻoki ʻana i ke ʻoki pinepine pinepine ʻia, a loaʻa iā lākou kahi o nā pilikia a me nā hopena ʻaoʻao. No laila, pono e noʻonoʻo i nā koho hoʻokele olakino ʻē aʻe e like me ka cannabis lāʻau. ”
ʻO nā ʻoihana ola olakino a me nā mea maʻi kūpono ma luna o ka makahiki 18 e ʻimi nei i nā kikoʻī e pili ana i ka Endometriosis Study a i ʻole nā lāʻau lapaʻau lāʻau cannabis hiki ke hoʻopili iā CA Clinics ma 1300 991 477 [pale ʻia ka leka uila]
NO NĀ NINAU MEDIA: [pale ʻia ka leka uila] a i ʻole kelepona iā 0412 372 158
Loaʻa NO KA NINAU:
-Louis Williams, Luna Hoʻokele o Aruma
-Dr Mark Hardy, Luna Hoʻokele Kauka CA Clinics
-Dr John Barlow, Noiabisu noiʻi noi ʻia
-ʻO ka mea maʻi i kau ʻia i ka lāʻau lapaʻau no ka endometriosis
NO ARUMA
ʻO Aruma kahi hui Australian Life Science i loea i ka noiʻi, hoʻomohala a me ka hana ʻana i nā mea lapaʻau kiʻekiʻe, cannabinoid-based therapeutics e mālama i nā pono olakino. Manaʻo ʻo Aruma e hoʻoulu i ka manaʻolana a hāʻawi i nā pono lapaʻau no ka mea maʻi e ʻimi nei i nā koho lapaʻau palekana a hilinaʻi i nā lāʻau lapaʻau kuʻuna.
* NO CACOS (CA Nānā Nānā Nānā Haumāna)
Hoʻohui ʻo CACOS e ʻohiʻohi i nā ʻike nānā e pili ana i ka hopena palekana a me nā hopena pili i ke olakino i nā maʻi e kuhikuhi ʻia nā huahana cannabis lāʻau ma o CA Clinics He noiʻi nānā e hōʻiliʻili i ka ʻike mai nā maʻi a me kā lākou mālama ʻana i nā kauka e pili ana i ko lākou ola e pili ana i ke olakino a me nā hanana maikaʻi ʻole i ʻike ʻia me ka lāʻau lapaʻau cannabis. Pākuʻi ʻia ʻo CACOS i nā huahana like ʻole, kahi e ʻohiʻohi ʻia nei e ʻikepili a wehewehe i ka lāʻau cannabis no ka nui o nā ʻano refractory.
E pili ana i ka noiʻi CANNABIS i noi ʻia
ʻO Applied Cannabis Research, kahi mahele o ka South Cannabis Holdings, kahi ʻoihana noiʻi ʻaelike loea e hāʻawi ana i ka ʻike noiʻi a me nā lawelawe i nā ʻoihana cannabis lāʻau lapaʻau a me nā poʻe ʻē aʻe e makemake ana i ka lāʻau cannabis lāʻau. [pale ʻia ka leka uila], (+61) 2 8294 6406 @CannabisApplied
He aha e lawe ʻia mai kēia ʻatikala:
- -The Endometriosis Study is a sub-study of CACOS, an observational study on the health outcomes of 3,000 patients nationwide at CA Clinics that are prescribed medicinal cannabis products for treatment of refractory conditions.
- -Endometriosis is estimated to affect more than 11% of Australian women and the reduced quality of life is estimated to result in a societal cost of $4 billion a year.
- E komo ana nā wahine 200 i ke aʻo ʻana e kiaʻi i ka palekana a me ka pono o ka lāʻau hiki ke hoʻohana ʻia me kahi koho hoʻoponopono a me ke koho hoʻomalu no ka ʻeha mau loa o ka refractory, kahi ʻōuli maʻamau o ka endometriosis.
